When THC attaches to the receptor, the effect is like an off switch to a light bulb, effectively turning "off" the pain. But ...

The Food and Drug Administration (FDA) has approved Journavx™ (suzetrigine) for the treatment of moderate to severe acute pain in adults.

In 2004, a research group at Peking University First Hospital discovered a mutation in the gene coding for a sodium-channel ...

The Food and Drug Administration announced the approval of a new non-opioid pain medication this week, marking the first time ...

The FDA on Thursday approved a new class of pain medication that provides an alternative to opioids. It will be sold under ...

WASHINGTON — Federal officials on Thursday approved a new type of pain pill designed to eliminate the risks of addiction and ...

Anti-CGRP antibodies vs onabotulinumtoxinA is not associated with increased cardiovascular disease risk in older patients ...

SAN DIEGO, CA and SOUTH SAN FRANCISCO, CA / ACCESS Newswire / January 21, 2025 / Dermata Therapeutics, Inc. (NASDAQ:DRMA)(NASDAQ:DRMAW) ("Dermata") and Revance ...

Cervical dystonia (≥5%): headache (9%), injection site pain (8%), injection ... in the U.S. Revance has also partnered with Viatris Inc. to develop a biosimilar to onabotulinumtoxinA for injection and ...

Revance's portfolio includes Daxxify® (DaxibotulinumtoxinA-lanm) for injection and the RHA® Collection of dermal fillers in the U.S. Revance has also partnered with Viatris Inc. to ...

Migraine is a neurological condition. The hallmark symptom of migraine is an intense headache, often described as pounding or throbbing. It’s usually accompanied by other symptoms like nausea ...

People with migraine headaches who got Botox injections for wrinkles reported getting fewer headaches than before they had Botox. A typical place to get Botox injections for migraine is on your ...